Anavex Life Sciences (GB:0HFR)
LSE:0HFR
Holding GB:0HFR?
Track your performance easily

Anavex Life Sciences (0HFR) Financial Statements

0 Followers

Anavex Life Sciences Financial Overview

Anavex Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.501; its P/E ratio is -11.17; Anavex Life Sciences is scheduled to report earnings on November 25, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -14.08M$ -12.67M$ -11.29M$ -12.17M$ -13.07M
EBITDA$ -14.08M$ -12.67M$ -11.29M$ -12.17M$ -13.07M
Net Income Common Stockholders$ -12.74M$ -10.55M$ -8.62M$ -10.15M$ -11.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 138.76M$ 139.39M$ 143.76M$ 151.02M$ 154.82M
Total Assets$ 141.53M$ 144.52M$ 148.07M$ 154.39M$ 157.81M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -138.76M$ -139.39M$ -143.76M$ -151.02M$ -154.82M
Total Liabilities$ 11.66M$ 9.56M$ 12.49M$ 12.53M$ 11.06M
Stockholders Equity$ 129.87M$ 134.96M$ 135.57M$ 141.85M$ 146.75M
Cash Flow-
Free Cash Flow$ -5.18M$ -11.66M$ -7.32M$ -5.85M$ -7.65M
Operating Cash Flow$ -5.18M$ -11.66M$ -7.32M$ -5.85M$ -7.65M
Investing Cash Flow-----
Financing Cash Flow$ 4.55M$ 7.28M$ 59.00K$ 2.06M$ 9.00M
Currency in USD

Anavex Life Sciences Earnings and Revenue History

Anavex Life Sciences Debt to Assets

Anavex Life Sciences Cash Flow

Anavex Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis